Stock Symbol:   

Stoxline Mobile
Home  |  Stock Charts  |  Showcases  |  Stock Ranks  |  Options  |  ETFs  |  Educations  |  Forex Crypto

Zoetis Inc. (ZTS)

166.44   2.29 (1.4%) 03-31 16:05
Open: 165.1 Pre. Close: 164.15
High: 166.49 Low: 164.03
Volume: 1,705,002 Market Cap: 77,126(M)

Technical analysis

as of: 2023-03-31 4:23:26 PM
Stoxline posted a STRONG BUY today, upgraded from lower rating. Upward movement to be expected.
Target: Six months: 200.87     One year: 234.61
Support: Support1: 164.21    Support2: 159.41
Resistance: Resistance1: 171.97    Resistance2: 200.87
Pivot: 164.34
Moving Average: MA(5): 164.79     MA(20): 164.97
MA(100): 157.77     MA(250): 162.6
MACD: MACD(12,26): -0.4     Signal(9): -0.4
Stochastic oscillator: %K(14,3): 53.4     %D(3): 47.7
RSI: RSI(14): 52.7
52-week: High: 201.32  Low: 124.15
Average Vol(K): 3-Month: 2,133 (K)  10-Days: 1,663 (K)

Price, moving averages and Bollinger Bands

Price has closed above its short-term moving average. Short-term moving average is currently below mid-term; and above long-term moving average. From the relationship between price and moving averages: This stock is NEUTRAL in short-term; and NEUTRAL in mid-long term.
[ ZTS ] has closed below upper band by 18.2%. Bollinger Bands are 62.2% narrower than normal. The narrow width of the bands suggests low volatility as compared to its normal range. The bands have been in this narrow range for 5 bars. This is a sign that the market may be about to initiate a new trend.

Stock Price Prediction

Update at 5:00pm EST
If tomorrow: Open lower Open higher
High: 166.64 - 167.29 167.29 - 168.02
Low: 162.27 - 162.96 162.96 - 163.76
Close: 165.09 - 166.21 166.21 - 167.5

Company Description

Zoetis Inc. discovers, develops, manufactures, and commercializes animal health medicines, vaccines, and diagnostic products in the United States and internationally. It commercializes products primarily across species, including livestock, such as cattle, swine, poultry, fish, and sheep; and companion animals comprising dogs, cats, and horses. The company also offers vaccines, which are biological preparations to prevent diseases of the respiratory, gastrointestinal, and reproductive tracts or induce a specific immune response; anti-infectives that prevent, kill, or slow the growth of bacteria, fungi, or protozoa; and parasiticides that prevent or eliminate external and internal parasites, which include fleas, ticks, and worms. It also provides other pharmaceutical products that comprise pain and sedation, antiemetic, reproductive, and oncology products; dermatology products for itch associated with allergic conditions and atopic dermatitis; and medicated feed additives, which offer medicines to livestock. In addition, the company provides portable blood and urine analysis testing, including point-of-care diagnostic products, instruments and reagents, rapid immunoassay tests, reference laboratory kits and services, and blood glucose monitors; and other non-pharmaceutical products, including nutritionals and agribusiness services, as well as products and services in areas, such as biodevices, genetics tests, and precision animal health. It markets its products to veterinarians, livestock producers, and retail outlets, as well as third-party veterinary distributors through its sales representatives, and technical and veterinary operations specialists. The company was founded in 1952 and is headquartered in Parsippany, New Jersey.

Headline News

Fri, 31 Mar 2023
Terra Nova Asset Management LLC Has $1.71 Million Stock ... - MarketBeat

Thu, 30 Mar 2023
Zoetis to Host Webcast and Conference Call on First Quarter 2023 Financial Results - Yahoo Finance

Thu, 30 Mar 2023
Guru Fundamental Report for ZTS - Nasdaq

Wed, 29 Mar 2023
Vestmark Advisory Solutions Inc. Trims Stock Holdings in Zoetis Inc ... - MarketBeat

Sun, 26 Mar 2023
Perfromance Wealth Partners LLC Sells 11990 Shares of Zoetis Inc ... - MarketBeat

Sat, 25 Mar 2023
Congress Asset Management Co. MA Reduces Its Holdings in ... - Best Stocks

Financial Analysis

Price to Book Value: Outperform
P/BV, a ratio used to compare book value to its current market price, to gauge whether a stock is valued properly.
Price to Earnings: Outperform
PE, the ratio for valuing a company that measures its current share price relative to its earnings per share (EPS).
Discounted cash flow: Outperform
DCF, a valuation method used to estimate the value of an investment based on its expected future cash flows.
Return on Assets: Neutral
ROA, indicates how profitable a company is in relation to its total assets, how efficiently uses assets to generate a profit.
Return on Equity: Outperform
ROE, a measure of financial performance calculated by dividing net income by equity. a gauge of profitability and efficiency.
Debt to Equity: Outperform
evaluate financial leverage, reflects the ability of equity to cover outstanding debts in the event of a business downturn.
Free Technical Analysis Charts

Stock Basics & Statistics

Exchange:  NYSE
Sector:  Healthcare
Industry:  Drug Manufacturers—Specialty & Generic
Shares Out. 463 (M)
Shares Float 463 (M)
% Held by Insiders 0.2 (%)
% Held by Institutions 94.4 (%)
Shares Short 4,240 (K)
Shares Short P.Month 4,190 (K)

Stock Financials

EPS 4.51
EPS Est Next Qtl 0.64
EPS Est This Year 2.33
EPS Est Next Year 2.68
Book Value (p.s.) 9.5
Profit Margin (%) 26.1
Operating Margin (%) 36.3
Return on Assets (ttm) 12.7
Return on Equity (ttm) 47.1
Qtrly Rev. Growth 3.7
Gross Profit (p.s.) 12.14
Sales Per Share 17.43
EBITDA (p.s.) 7.18
Qtrly Earnings Growth 12.5
Operating Cash Flow 1,910 (M)
Levered Free Cash Flow 1,170 (M)

Stock Valuations

PE Ratio 36.81
PEG Ratio 2.8
Price to Book value 17.51
Price to Sales 9.54
Price to Cash Flow 40.36

Stock Dividends

Dividend 0.37
Forward Dividend 0
Dividend Yield 0.2%
Dividend Pay Date 2022-02-28
Ex-Dividend Date 2022-01-18
Your Ad Here
StockChart iOS
StoxlineLite iOS
StoxlineLite iOS
OptionCalc iOS
StockChart Android
StoxlineLite Android
StoxlinePro Android
OptionCalc Android
(c) 2006-2022 | Contact us           
Data and information is provided for informational purposes only, and is not intended for trading purposes. Neither nor its data provider shall be liable for any errors or delays in the content, or for any actions taken in reliance thereon. By accessing the web site, a user agrees not to redistribute the information found therein.